Abstract
Systemic inflammation and elevations in the hormone fibroblast growth factor 23 (FGF23) contribute to cardiac injury and death in patients with kidney disease. A new mechanistic study by Courbon et al. suggests that the bone connects the damaged kidney with the damaged heart by serving as the target for a kidney-derived proinflammatory factor and responding with FGF23 secretion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
